Product NDC: | 25021-601 |
Proprietary Name: | caffeine citrate |
Non Proprietary Name: | caffeine citrate |
Active Ingredient(s): | 20 mg/mL & nbsp; caffeine citrate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-601 |
Labeler Name: | Sagent Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA090827 |
Marketing Category: | ANDA |
Start Marketing Date: | 20120915 |
Package NDC: | 25021-601-03 |
Package Description: | 1 VIAL in 1 CARTON (25021-601-03) > 3 mL in 1 VIAL |
NDC Code | 25021-601-03 |
Proprietary Name | caffeine citrate |
Package Description | 1 VIAL in 1 CARTON (25021-601-03) > 3 mL in 1 VIAL |
Product NDC | 25021-601 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | caffeine citrate |
Dosage Form Name | SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20120915 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | CAFFEINE CITRATE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |